Literature DB >> 33654197

The role of miR-200b/c in balancing EMT and proliferation revealed by an activity reporter.

Paradesi Naidu Gollavilli1, Beatrice Parma1, Aarif Siddiqui1,2, Hai Yang3, Vignesh Ramesh1, Francesca Napoli1,4, Annemarie Schwab1, Ramakrishnan Natesan5, Dirk Mielenz6, Irfan Ahmed Asangani5, Thomas Brabletz7, Christian Pilarsky3, Paolo Ceppi8,9.   

Abstract

Since their discovery, microRNAs (miRNAs) have been widely studied in almost every aspect of biology and medicine, leading to the identification of important gene regulation circuits and cellular mechanisms. However, investigations are generally focused on the analysis of their downstream targets and biological functions in overexpression and knockdown approaches, while miRNAs endogenous levels and activity remain poorly understood. Here, we used the cellular plasticity-regulating process of epithelial-to-mesenchymal transition (EMT) as a model to show the efficacy of a fluorescent sensor to separate cells with distinct EMT signatures, based on miR-200b/c activity. The system was further combined with a CRISPR-Cas9 screening platform to unbiasedly identify miR-200b/c upstream regulating genes. The sensor allows to infer miRNAs fundamental biological properties, as profiling of sorted cells indicated miR-200b/c as a molecular switch between EMT differentiation and proliferation, and suggested a role for metabolic enzymes in miR-200/EMT regulation. Analysis of miRNAs endogenous levels and activity for in vitro and in vivo applications could lead to a better understanding of their biological role in physiology and disease.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33654197      PMCID: PMC7994202          DOI: 10.1038/s41388-021-01708-6

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  60 in total

1.  NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.

Authors:  Margit A Huber; Ninel Azoitei; Bernd Baumann; Stefan Grünert; Andreas Sommer; Hubert Pehamberger; Norbert Kraut; Hartmut Beug; Thomas Wirth
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 2.  Targeting EMT in Cancer with Repurposed Metabolic Inhibitors.

Authors:  Vignesh Ramesh; Thomas Brabletz; Paolo Ceppi
Journal:  Trends Cancer       Date:  2020-07-15

3.  Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer.

Authors:  Paolo Ceppi; Giridhar Mudduluru; Regalla Kumarswamy; Ida Rapa; Giorgio V Scagliotti; Mauro Papotti; Heike Allgayer
Journal:  Mol Cancer Res       Date:  2010-08-09       Impact factor: 5.852

Review 4.  The epithelial-mesenchymal transition (EMT) phenomenon.

Authors:  P Savagner
Journal:  Ann Oncol       Date:  2010-10       Impact factor: 32.976

Review 5.  MicroRNAs linking inflamm-aging, cellular senescence and cancer.

Authors:  Fabiola Olivieri; Maria Rita Rippo; Vladia Monsurrò; Stefano Salvioli; Miriam Capri; Antonio Domenico Procopio; Claudio Franceschi
Journal:  Ageing Res Rev       Date:  2013-05-17       Impact factor: 10.895

6.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.

Authors:  Philip A Gregory; Andrew G Bert; Emily L Paterson; Simon C Barry; Anna Tsykin; Gelareh Farshid; Mathew A Vadas; Yeesim Khew-Goodall; Gregory J Goodall
Journal:  Nat Cell Biol       Date:  2008-03-30       Impact factor: 28.824

Review 7.  Oncomirs - microRNAs with a role in cancer.

Authors:  Aurora Esquela-Kerscher; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

8.  MicroRNAs can generate thresholds in target gene expression.

Authors:  Shankar Mukherji; Margaret S Ebert; Grace X Y Zheng; John S Tsang; Phillip A Sharp; Alexander van Oudenaarden
Journal:  Nat Genet       Date:  2011-08-21       Impact factor: 38.330

9.  Cell-Based Reporter System for High-Throughput Screening of MicroRNA Pathway Inhibitors and Its Limitations.

Authors:  Katerina Brustikova; David Sedlak; Jana Kubikova; Ctibor Skuta; Katerina Solcova; Radek Malik; Petr Bartunek; Petr Svoboda
Journal:  Front Genet       Date:  2018-02-27       Impact factor: 4.599

10.  Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells.

Authors:  Cornelia Kröger; Alexander Afeyan; Jasmin Mraz; Elinor Ng Eaton; Ferenc Reinhardt; Yevgenia L Khodor; Prathapan Thiru; Brian Bierie; Xin Ye; Christopher B Burge; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-25       Impact factor: 11.205

View more
  6 in total

1.  Prognostic and Predictive Effects of Tumor and Plasma miR-200c-3p in Locally Advanced and Metastatic Breast Cancer.

Authors:  Esther Navarro-Manzano; Ginés Luengo-Gil; Rocío González-Conejero; Elisa García-Garre; Elena García-Martínez; Esmeralda García-Torralba; Asunción Chaves-Benito; Vicente Vicente; Francisco Ayala de la Peña
Journal:  Cancers (Basel)       Date:  2022-05-12       Impact factor: 6.575

Review 2.  Revisiting the miR-200 Family: A Clan of Five Siblings with Essential Roles in Development and Disease.

Authors:  Vignesh Sundararajan; Ulrike C Burk; Karolina Bajdak-Rusinek
Journal:  Biomolecules       Date:  2022-06-03

Review 3.  The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers.

Authors:  Ilaria Cavallari; Francesco Ciccarese; Evgeniya Sharova; Loredana Urso; Vittoria Raimondi; Micol Silic-Benussi; Donna M D'Agostino; Vincenzo Ciminale
Journal:  Cancers (Basel)       Date:  2021-11-23       Impact factor: 6.639

4.  Regulation of XPO5 phosphorylation by PP2A in hepatocellular carcinoma.

Authors:  Jiao Li; Jian-Kang Zhou; Xiaoyu Mu; Shu Shen; Xiaomin Xu; Yao Luo; Yuxin Luo; Yue Ming; Yuangang Wu; Yong Peng
Journal:  MedComm (2020)       Date:  2022-04-15

Review 5.  The role of miR-200 family in the regulation of hallmarks of cancer.

Authors:  Klaudia Klicka; Tomasz M Grzywa; Aleksandra Mielniczuk; Alicja Klinke; Paweł K Włodarski
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

6.  Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting.

Authors:  Beatrice Parma; Vignesh Ramesh; Paradesi Naidu Gollavilli; Aarif Siddiqui; Luisa Pinna; Annemarie Schwab; Sabine Marschall; Shuman Zhang; Christian Pilarsky; Francesca Napoli; Marco Volante; Sophia Urbanczyk; Dirk Mielenz; Henrik Daa Schrøder; Marc Stemmler; Heiko Wurdak; Paolo Ceppi
Journal:  J Exp Clin Cancer Res       Date:  2021-08-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.